Literature DB >> 25939432

Enhanced epidermal localization of topically applied steroids using SPACE™ peptide.

Sunny Kumar1, Ming Chen, Aaron C Anselmo, John A Muraski, Samir Mitragotri.   

Abstract

The balance of efficacy and safety of topical corticosteroids (TCs) depends on their ability to penetrate into and be retained within the skin. Here, we evaluated the ability of SPACE™ peptide to enhance epidermal delivery and localization of three model TCs. In vitro and in vivo skin penetration studies were performed to evaluate penetration of TCs into and across the skin in the presence of various formulations of SPACE™ peptide. Topical formulations of corticosterone containing free SPACE™ peptide produced significantly enhanced epidermal penetration and localization. Ratio of drug deposition in the skin and receiver (efficacy/safety, indicative of ratio of local to systemic uptake) exhibited higher values for SPACE™ peptide-based formulation as compared to aqueous and hydroethanolic solutions and Cortizone™ cream. Mass spectrometry analysis showed that SPACE™ peptide associates with corticosterone, which may explain its enhanced retention effect. SPACE™ peptide also enhanced dermal retention of two more TCs (hydrocortisone and triamcinolone acetonide) compared to the vehicle control. An in vivo study in mice further established the ability of SPACE™ peptide to enhance skin retention of hydrocortisone without producing elevated blood concentrations. These results show that SPACE™ peptide is an effective additive to the formulation for enhanced skin localization of topical steroids.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25939432     DOI: 10.1007/s13346-015-0232-4

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  34 in total

1.  EXISTENCE OF RESERVOIR IN THE STRATUM CORNEUM. EXPERIMENTAL PROOF.

Authors:  C F VICKERS
Journal:  Arch Dermatol       Date:  1963-07

2.  Relationships between skin's electrical impedance and permeability in the presence of chemical enhancers.

Authors:  Pankaj Karande; Amit Jain; Samir Mitragotri
Journal:  J Control Release       Date:  2005-11-28       Impact factor: 9.776

3.  Penetration kinetics of liposomal hydrocortisone in human skin.

Authors:  W Wohlrab; J Lasch
Journal:  Dermatologica       Date:  1987

4.  Calcium phosphate nanoparticles for transcutaneous vaccine delivery.

Authors:  Preety Sahdev; Satheesh Podaralla; Radhey S Kaushik; Omathanu Perumal
Journal:  J Biomed Nanotechnol       Date:  2013-01       Impact factor: 4.099

5.  Identification of a novel skin penetration enhancement peptide by phage display peptide library screening.

Authors:  Sunny Kumar; Preety Sahdev; Omathanu Perumal; Hemachand Tummala
Journal:  Mol Pharm       Date:  2012-04-16       Impact factor: 4.939

Review 6.  New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use.

Authors:  Benedetta Brazzini; Nicola Pimpinelli
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

7.  In vitro enhancement of lactate esters on the percutaneous penetration of drugs with different lipophilicity.

Authors:  Jianhua Zhang; Mei Liu; Hongjian Jin; Liandong Deng; Jinfeng Xing; Anjie Dong
Journal:  AAPS PharmSciTech       Date:  2010-05-22       Impact factor: 3.246

8.  Stability and transdermal absorption of topical amphotericin B liposome formulations.

Authors:  A Manosroi; L Kongkaneramit; J Manosroi
Journal:  Int J Pharm       Date:  2004-02-11       Impact factor: 5.875

9.  Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies.

Authors:  Hetal K Patel; Bhavesh S Barot; Punit B Parejiya; Pragna K Shelat; Arunkumar Shukla
Journal:  Colloids Surf B Biointerfaces       Date:  2012-08-16       Impact factor: 5.268

10.  Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments.

Authors:  A Henning; D Neumann; K-H Kostka; C-M Lehr; U F Schaefer
Journal:  Skin Pharmacol Physiol       Date:  2008-01-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.